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Epidemiologic and experimental studies would lead us to  believe 
that most human beings who come in contact with the virus of polio- 
myelitis develop immunity, only the occasional susceptible individual 
succumbing to  the paralytic disease.  Events are  very different  in 
the experimental animal.  Monkeys (rhesus) are essentially uniformly 
susceptible to experimental infection, and exposure to the virus either 
results in the experimental disease, or, provoking no response, leaves 
the animal susceptible to subsequent infection.  So far as our knowl- 
edge goes, immunity develops in the monkey only through an attack 
of the experimental disease or by vaccination. 
In a  preliminary communication  t we reported briefly on apparent 
successful alteration in susceptibility of rhesus monkeys to intranasal 
instillations of potent virus, and the subsequent development in most 
of the resistant animals of what appears to be an active immunity, as 
indicated by both the neutralization and intracerebral tests.  We had, 
it appeared, succeeded in vaccinating the animals by the nasal route, 
to the best of our knowledge a hitherto unrecorded phenomenon.  In 
the present paper we wish to present in detail the procedures and 
further results of the experiments which we believe are  significant 
from epidemiologic and theoretical points of view, and which perhaps 
may have some practical bearing. 
* This work was supported by a grant from the President's Birthday Ball Com- 
mission for Infantile Paralysis Research. 
l Kramer, S. D., Grossman, L. H., and Parker, G. C., Proc. Soc. Exp. Biol. and 
Med., 1936-37,  370. 
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Materials and Methods 
Materials.--1. Surgical pituitrin (pituitrin S). 
2.  A mixture of adrenalin and ephedrine sulfate, in proportions of 1 : 10,000  of 
the former and 2 per cent of the latter, with 0.5 per cent chloretone as a preserva- 
tive.  This mixture is known commercially as adrephine. 
3.  A  5 per cent suspension of ground centrifugalized virus (Armstrong strain) 
was employed for intranasal infection.  This strain proved to be potent; bringing 
down control animals in 7 to 9 days. 
4.  Our own laboratory strain, VM  11,  was employed for neutralization and 
intracerebral tests, prepared as previously described  z in large batches, and titrated 
every 2  or 3  months.  The infective dose employed was two to ten times  the 
minimal dose of virus necessary to bring down every animal in duplicate or tripli- 
cate titrations. 
Procedure.--Healthy normal rhesus monkeys were selected.  The animals were 
held in supine position with the head retracted; 0.5  cc. of pituitrin S  was first 
instilled into each nostril by the dropper method; 5 minutes later 1 cc. of adrephine 
was dropped into each nostril.  Following this treatment, and at stated intervals 
which varied in the different experiments, 1 cc. of a  5 per cent  centrifugalized 
suspension of poliomyelitis virus (Armstrong strain) was instilled into each nostril 
Resistance to intranasal infection was determined by instillations of 1 cc. of a 
5 per cent suspension of the potent Armstrong virus into each nostril daily for 3 
successive days (intranasal test). 
Neutralization tests were carried out in the manner previously described.  2  The 
animals were bled at varying intervals during the experimental period.  1 cc. of 
the undiluted serum to be tested was mixed with 1 cc, of virus, representing two 
infective doses (determined as described above) of a 5 per cent suspension of VM 
11, in 1 cc. of saline.  The mixture was incubated for 2 hours at 37°C., kept in the 
ice chest overnight, and 1.2 cc. of this mixture was inoculated intracerebrally into 
test animals. 
The intracerebral test consisted of inoculating into the left or right frontal lobe 
of the experimental animal an infective dose of virus (in 1 cc. of saline). 
All intranasal,  neutralization,  and  intracerebral tests  were  accompanied by 
normal controls, to check the potency of the virus. 
Protective Action  of Pituitrin  S  and Adrephine  (5 Days Preliminary 
Treatment) 
Experiment/.--Each  of 7 animals received pituitrin S  and adrephine as de- 
scribed above, every 12 hours for 5 days, or ten instillations in all.  12 hours after 
the last instillation, each animal received 1 ce. of the virus suspension into each 
nostril on 3 successive days.  One animal died of dysentery.  Of the 6 remaining 
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animals, 2 succumbed, 4 resisted infection. Of the 4 surviving animals, one received 
a second series of three nasal instillations of virus  15  days after the first intra- 
nasal test.  This animal died of tuberculosis 25 days later.  A second intranasal 
test was done on one animal 75 days after the first nasal test, the remaining 2 
animals were tested 100 days after the first intranasal test.  All 3 animals survived. 
Neutralization tests performed on three serums obtained 18 days and one obtained 
57 days after the first exposure to the virus, showed that 2 animals had developed 
neutralizing substance; two serums failed to neutralize.  An intracerebral test per- 
formed on  2  animals  111  days and  on one animal 86  days after the first intra- 
nasal test resulted in the experimental disease in all 3 animals; one animal develop- 
ing a  mild attack from which it recovered.  Of the 14 controls used, all but one 
succumbed within the usual incubation period of the virus; the single survivor 
being one of the 4 used as intranasal controls. 
Experiment 2.--Each of 6 animals was treated with pitnitrin S and adrephine, 
for 5 days, in the same manner as the animals in Experiment 1.  24 hours after 
the last treatment, 2 of this group received the first of three daily doses of virus 
intranasally; 1 cc. into each nostril.  2 additional animals received the first of three 
daily doses 48 hours after the last treatment, and the last 2 animals received virus 
96 hours after the last treatment.  The 2 animals which were infected 24 hours 
after the last treatment resisted infection.  Of the remainder, 2 succumbed to the 
disease, a third, No. 9-3, died of a rapidly progressing anemia, and the other died 
an  accidental death.  Neutralization tests  were  done  on  the  serums  of  the  2 
survivors, obtained 21  days after the last inoculation with virus; both  serums 
neutralized.  A second intranasal test was performed 43 days after the first series 
of intranasal instillations; both animals survived.  Intracerebral tests were per- 
formed 56 days after the first intranasal test; one animal survived and one suc- 
cumbed after a prolonged incubation period (27 days).  All of the 11 controls used 
in this experiment succumbed to the disease. 
Protective Action of Pituitrin S  and Adrephine  (7 Days of Treatment) 
Experiment 3.--Six animals received two daily instillations of pituitrin S and 
adrephine 12 hours apart for 7 days.  24 hours after the last treatment (Sth day), 
2 of these animals received the first of three daily intranasal doses of virus; a second 
pair of animals received the first intranasal dose of virus 48 hours after the last 
treatment; and the last 2, 96 hours after the last treatment.  Both animals infected 
96 hours after the last treatment succumbed.  One of the 2 animals infected 48 
hours after the treatment succumbed and one survived.  Both animals infected 24 
hours  after the last treatment survived.  Neutralization tests were done on the 
serums of the 3 surviving animals, obtained 24 days after the third instillation of 
virus; two neutralized and  one  failed to  do  so.  The  animals  were  tested  in- 
tranasally a  second time 26 and 27  days after the first intranasal test; all sur- 
vived.  Intracerebral tests performed 40 to 41 days after the first intranasal test, 
resulted in the experimental disease in 2  of the 3 animals.  All 10 controls suc- 
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Of the  19 animals included in these  three experiments, 9  survived 
the intranasal  test and  2  died from causes other  than poliomyelitis. 
6  of the group developed neutralizing  substance in the blood serum, 
2  of  these  6  withstanding  intracerebral  inoculation.  One  animal 
succumbed  to  the  intracerebral  test  after  a  prolonged  incubation 
period (27 days), and a second succumbed to a mild attack from which 
it recovered.  Of the 9 animals, all but one had received virus 12 to 24 
hours after completion of the treatment with pituitrin S and adrephine; 
the  ninth  animal  received  virus  48  hours  after  the  last  treatment. 
The animals which had received virus after 96 hours,  all succumbed. 
34 of the 35 controls used in these 4 experiments developed the experi- 
mental disease. 
Action of Pituitrin S  and Adrephine in Combination with Virus 
Experiment 4.--2 animals received daily instillations of both  pituitrin S and 
adrephine, as well as virus.  The pituitrin S and adrephine were  instilled  at 11 
a.m. and the virus at 5 p.m.  One of these animals succumbed to the disease in 11 
days; the control having come down in 7 days.  Daily treatment with pituitrin S 
and adrephine and instillations of virus was continued on the surviving animal for 
28 days when it was discontinued, and on the 29th, 30th, and 31st days the animal 
received instillations of virus alone.  The animal survived.  Serum, obtained 29 
days after the beginning of the experiment, failed to neutralize the virus.  9 days 
after the intranasal test, the animal was inoculated intracerebrally with an infec- 
tive dose of a 5 per cent suspension  of virus in 1 cc. of saline and survived.  All 6 
controls succumbed to the experimental disease. 
Experiment 5.--4 animals  received daily two treatments of pituitrin  S  and 
adrephine (at 9 a.m. and 5 p.m. respectively).  At 1 p.m., or 4 hours after the first 
treatment, the animals received 1 cc. of a 5 per cent suspension  of virus into each 
nostril.  2 of the group succumbed  to the experimental disease  in 9 days.  The 
remaining animals survived 20 days of treatment and nasal instillations of virus, 
at which time the treatment and virus instillations were discontinued.  They were 
tested by intranasal instillations  of virus on the  21st, 22nd, and  23rd days; both 
survived.  Neutralization tests  were performed on the serums of these animals, 
obtained 20 days after the beginning of the experiment; both neutralized.  Intra- 
cerebral tests were performed 9 days after the last intranasal test; both animals 
survived.  All 5 controls employed in this experiment succumbed. 
Experiment 6.---4 additional animals received the same daily treatments and 
exposures to virus as in Experiment 5.  One animal succumbed in 9 days after 
the last inoculation of virus; 3 survived 22 days of treatment and exposure to virus. 
Neutralization tests were done on the serums obtained 22 days from the beginning 
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one failed to neutralize.  Intracerebral tests were done 23 days from the time the 
experiment was started; one animal succumbed to the experimental disease and 2 
survived.  The 4 controls employed in this experiment succumbed. 
The survival of 5 animals in the above three experiments suggested 
the development not only of resistance to intranasal infection, but 
apparently of an active immunity, as indicated by their resistance to 
intracerebral inoculation and the appearance of neutralizing substance 
in the blood serums.  These experiments were therefore repeated. 
Experiments 7 and &--One group of 4 animals (Experiment 7), received daily 
for 31 days a single instillation of pituitrin S and adrephine at 11 a.m., followed by 
virus at 5 p.m.  A Second group of 4 animals (Experiment 8), received daily for 31 
days two treatments with pituitrin S and adrephine at 9 a.m. and 5 p.m. respec- 
tively, combined with virus instilled at 1 p.m.  Only one of the animals which had 
received a  single treatment of pituitrin S and adrephine survived.  That  single 
animal, however, developed neutralizing substance in its serum 31 days after the 
beginning of the  treatment,  survived an intranasal test, and resisted the intra- 
cerebral test  done  54 days from the beginning of the experiment.  3  of the 4 
animals which had received two treatments and one instillation of virus survived; 
all 3 withstood an intranasal test and 2 resisted an intraeerebral inoculation.  Only 
one of the 3  animals developed demonstrable neutralizing substance, and  that 
animal was one of the 2  that resisted the intracerebral test.  All 22  controls in 
these two experiments succumbed. 
Of the  18  animals used in  these five  experiments, which had re- 
ceived treatment with pituitrin S and adrephine in combination with 
virus instillations,  10 survived.  2 of these 10 survivors belonged to 
the group which were treated with pituitrin S and adrephine once a 
day, the remaining 8 twice a day.  5 of the 10 survivors developed 
neutralizing substance in their blood.  7 of the animals were tested 
intranasally and all  survived.  8  of  the group  survived the intra- 
cerebral test.  All of the 37  controls used in these five experiments 
succumbed to the experimental disease. 
Action of Pituitrin S and Adrephine Administered in Combination with 
Virus Preceded by 5 Days Preliminary Treatment 
Experiment 9.--4 animals received preliminary treatment with pituitrin S and 
adrephine once a day for 5 days.  From the 6th day on and daily for 26 days they 
received instillations of pituitrin S and adrephine at 11 a.m., and of virus at 5 p.m. 
3 animals succumbed in 8,  11, and 18 days respectively.  The one animal which 
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treatment and virus instillations.  It resisted an intranasal test, and also intra- 
cerebral inoculation 54 days from the beginning of the experiment.  14 controls 
were used, all of which succumbed to the experimental disease. 
Experiment  10.--4  animals received preliminary treatments with pituitrin  S 
and adrephine, at 9 a.m. and 5 p.m. daily for 5 successive days.  On the 6th day, 
instillations of virus (administered at 1 p.m.) were combined with the treatment 
and continued for 26 days.  Of the 4 animals, one was found dead 17 days after 
the beginning of the experiment, but as indicated by histologic examination, not of 
poliomyelitis.  The 3 remaining animals survived.  All 3 developed neutralizing 
substance in their serums by the  26th day after the onset of the combined pro- 
cedure, resisted an intranasal test, and also an intracerebral test performed 54 days 
from the beginning of the experiment.  All  14 controls used in this experiment 
succumbed. 
In the following two experiments a spray was employed in introduc- 
ing  the  pituitrin  S  and  adrephine,  instead  of  the  pipette  as  in  the 
previous experiments. 
Experiment 11.----6 animals received a single application a day of pituitrin S and 
adrephine by the spray method on 5 successive days, and beginning with the 6th 
day and daily for 24 days the applications of pituitrin S and adrephine were admin- 
istered at 11 o'clock in the morning and virus dropped into the nostrils at 5 o'clock 
in the afternoon.  Of the 6 animals, 5 succumbed, in  from 9 to 23 days.  The 
single  survivor developed  neutralizing substance 24 days after the onset of the 
combined treatment and virus  instillations,  resisted an intranasal test, and sur- 
vived an intracerebral test performed 46 days from the onset  of the experiment. 
The 7 controls used in this experiment succumbed. 
Experiment 12.--8 animals received daily two treatments with pituitrin S and 
adrephine (at 9 a.m. and 5 p.m.  respectively), instilled  by spray on 5 successive 
days.  Treatment twice daily with pituitrin S and adrephine in combination with 
a single daffy instillation of virus at 1 p.m. was continued for 26 days.  7 of the 8 
animals survived this procedure.  5 of the 7 animals developed neutralizing sub- 
stance 26 days from the onset of the combined treatment and virus administration. 
6 of the group resisted an intranasal test and also the intracerebral test performed 
47 days from the beginning of the experiment.  All of the 11 controls succumbed 
to the experimental disease. 
Twenty-two animals were included in these four experiments.  All 
received preliminary treatment with  pituitrin  S  and  adrephine  for 5 
successive  days  and  this  was  followed  by  combined  treatment  and 
virus  administration.  12  survived.  Of  this  number  2  belonged  to 
the group which had received treatment with pituitrin S and adrephine 
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day.  11  of  the  12  animals  survived  intranasal  and  intracerebral 
tests,  l0 developed neutralizing substance in their blood. 
Protective Action of A drephine 
Experiment 13.--4 animals received 2 treatments with adrephine (at 9 a.m. and 
5  p.m.),  and  virus  at  1 p.m.  2  survived 37  combined daily treatments  with 
adrephine and instillations of virus.  Both of these animals developed neutralizing 
substance 37 days after the onset of the experiment; they both resisted an intra- 
nasal test and survived the intracerebral test, which was performed 59 days from 
the beginning of the experiment.  All of the 9 controls succumbed within  the 
incubation period of the disease. 
Experiment 14.--3 animals  received preliminary  treatments  with  adrephine 
twice a day for 5 days.  On the 6th day, 12 hours after the last treatment, the 
animals received the first of the 3 daily instillations for the intranasal test.  One 
of the 3 animals was found dead 2 days after the virus was first administered 
(dysentery).  The 2 remaining  animals  resisted  the  intranasal  test;  the  blood 
serum, obtained 21 days from the day the intranasal test was started, neutralized 
the virus.  Both animals resisted a second intranasal test done 21 days after the 
first, and both resisted intracerebral inoculation 33 days after the first intranasal 
test.  AM of the 7 controls succumbed to the experimental disease. 
Protective Action of Pituitrin S 
Experiment 15.--Three animals  were  treated  twice a  day  (at  9  a.m.  and  5 
p.m.), with pituitrin S alone, and given one instillation of virus daily at  1 p.m. 
All 3 animals succumbed from 18 to 21 days after the beginning of the experiment. 
The  results  of those  three  experiments  seem to  indicate  that  the 
protective action is largely due to the adrephine, the pituitrin S prob- 
ably playing  a  secondary  r61e.  This  is  in  accord  with  our  original 
idea,  since  the  pituitrin  S  was  used  to  prolong  the  action  of  the 
adrephine? 
Comparable Experiments  Using Solutions  of Alum Sulfate-Picric Add 
and Zinc Sulfate in Place of Pituitrin S  and A drephine 
Solutions  of  Alum  Sulfate-Picric  Acid.--In  the  following  three 
experiments an aqueous solution of 0.5  per cent each of alum  sulfate 
and picric acid  4 was used in place of pituitrin S and adrephine. 
* Suggested to us by Dr. Charles C. Haskell, chief toxicologist,  Ciba Company. 
4Armstrong, C.,  and  Harrison, W. T.,  Pub. Health Rep., U.S.P.H.S.,  1936, 
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Experiment 16.--3  animals  received  preliminary  instillations  of a  solution  of 
alum sulfate-picric  acid once a day for 5 successive days.  On the 6th, 7th, and 
8th days, the animals received nasal instillations  of 5 per cent potent virus,  1 cc. 
into each nostril.  2 of the 3 animals survived.  The serums of the surviving  an- 
imals failed to neutralize  the virus 24 days later;both survived a second intranasal 
test,  24 days after the first intranasal  test, and both animals  succumbed  to  the 
intracerebral  test 47  days  after  the  first  intranasal  test.  All  6  controls  suc- 
cumbed  to the experimental  disease. 
Experiment 17.--4 animals received preliminary  nasal instillations  once a day 
for 5 days with a solution of 0.5 per cent each of alum sulfate-picric acid, and from 
the 6th day on the animals received daily instillations  of alum sulfate-picric acid 
at 11 a.m., and instillations  of virus at 5 p.m.  All 4 animals succumbed 7 to 21 
days after the virus was started.  The 4 controls succumbed within the incuba- 
tion period of the virus. 
Experiment  18.--4  animals  received  preliminary  treatments  with  the  alum 
sulfate-picric  acid solution  for 5 days.  This  was  followed by daily intranasal 
instillations  of virus  alone.  3 of  the group succumbed  to frank attacks of the 
experimental  disease, and the fourth was found dead on the 14th  day, without 
having given  any clinical  signs or histologic evidence  of poliomyelitis.  The 4 
controls succumbed. 
The  results  of  these  experiments  seem  to  indicate  that  solutions 
containing mixtures of alum sulfate and picric acid convey only partial 
protection  to  intranasal  infection.  There  is  no  indication,  further- 
more, that prolonged exposure to virus alone, or in combination with 
solutions of alum sulfate and picric acid results in an active immunity. 
Solutions  of Zinc Sulfate.--In  the  following/our experiments,  0.5 
per cent solution of zinc sulfate  in  saline  5 was  employed in  place  of 
pituitrin S and adrephine. 
Experiment 19.--3 animals received daily for 5 days single instillations  of zinc 
sulfate, and on the 6th day the first of the three daily instillations  of virus.  All 3 
animals survived this first intranasal  test; 2 animals succumbed to a second intra- 
nasal  test  22 days later.  The animal which survived failed  to resist  the intra- 
cerebral  test performed  23 days after the second intranasal  test.  The serum of 
this animal  did not neutralize  the virus.  The 6 control  animals  succumbed  to 
the experimental disease. 
Experiment 20.--4 animals  received daily for 5 days single preliminary  treat- 
ments with a solution of zinc sulfate  and then single daily treatments with zinc 
5 Schultz,  E. W.,  and Gebhardt,  L. P., Proc. Soc. Exp.  Biol. and Med., 1937, 
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sulfate at 11 a.m., and instillations of virus at 5 p.m.  3 of the animals succumbed 
to  the  experimental  disease;  one  survived  26  days  of  combined  procedure  of 
treatment and virus administration.  The serum of the surviving animal, obtained 
27  days after the virus  was  first  given,  neutralized  but  death  by tuberculosis 
occurred  a  few days after the intracerebral  test was done.  6 of the 7 controls 
succumbed;  the one which failed to come down was one of the 4 animals used as 
intranasal  controls. 
.Experiment 21.--2 additional animals treated in the same manner as the animals 
in Experiment  18,  survived 30 days of treatment  and exposure to virus.  The 
serums of both animals failed to neutralize  the virus and they succumbed to the 
intracerebral  test performed  30 days from the beginning of the combined  treat- 
ment and administration of virus.  The 3 normal controls succumbed. 
Experiment 22.--4  animals  received  preliminary  treatments  of  single  daily 
instillations  with the zinc sulfate  solution for 5 days; this was followed by daily 
instillations of virus alone.  3 of the 4 animals survived 26 days; one succumbed in 
6 days.  The serum of 2 of the survivors failed to neutralize  the virus; while that 
of the third animal neutralized  on the first test and failed when repeated.  All 3 
animals succumbed to the intracerebral  test given 33 days after the beginning of 
the experiment.  The single animal,  whose serum  neutralized  the virus  on the 
first neutralization  test,  succumbed  to the intracerebral  test with an incubation 
period of 18 days.  6 of the 7 controls succumbed;  the single survivor was one of 
the 4 animals used as intranasal controls. 
It appears from these experiments that zinc sulfate offers effective 
protection  against  infection by the  intranasal  route  for  a  period  of 
about  a  month.  However,  these  animals  fail  to  give  any  definite 
evidence of the  development of  an  active  immunity,  following pro- 
longed daily exposure to the virus alone or in combination with zinc 
sulfate. 
Experiment to Determine Presence  or A bsence of Delayed Protection of 
Pituitrin S  and Adrephine 
Experiment 23.--Each of 6 animals  received  two daily instillations  12 hours 
apart  of pituitrin  S and aclrephine for  7 consecutive  days.  2 weeks later 2 of 
these animals received  the first of three daily intranasal  instillations  of 1 cc. of a 
5 per cent suspension of virus into each nostril;  the second 2 animals  were simi- 
larly  tested  by intranasal  instillations  of  virus 4 weeks after treatment  with 
pituitrin S and adrephine;  and the last 2 animals were tested  6 weeks after treat- 
ment.  No delayed protective action was evident.  5 animals  succumbed  to the 
intranasal test, and the sixth  died  of intercurrent  infection  shortly after the in- 
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Protective Action of Subcutaneous  Inoculations  of Pituitrin S  and 
Adrephine 
In the following experiment the protective action against intranasal 
infection  by pituitrin  S  and  adrephine,  when  these  substances  are 
administered  subcutaneously,  was  tested. 
Experiment 24.--3 animals were inoculated subcutaneously with 1 co. pituitrin 
S and 5 minutes later with 1 cc. adrephine.  This procedure was repeated twice 
daily, at an interval of 8 hours (9 a.m. and 5 p.m.) for 5 consecutive days.  On the 
6th day these 3 animals and 2 controls all received the first of three instillations of 
the intranasal test.  All of the animals succumbed, suggesting that subcutaneous 
injections of pituitrin S and adrephine afford no protection to intranasal infection. 
Effect  of Pituitrin  S  and  Adrephine  on  Some  of the  Formed  Blood 
Elements 
In the following two experiments an attempt was made to determine 
if there were alterations  in the  type or total number of some of the 
formed  blood  elements  following  the  administration  of  pituitrin  S 
and adrephine by the intranasal and subcutaneous routes.  The blood 
elements studied were total red and white cell counts and differential 
counts. 
Experiment 25.--A group of 6 normal animals was selected and blood studies 
were done daily for 4 days to establish the degree of variation in these dements. 
On the next day and on the 4 succeeding (5 days in all), the animals received intra- 
nasal instillations  of pituitrin S and adrephine twice daily, 12 hours apart (9 a.m. 
and 9 p.m.), and blood counts were done at 1 p.m.  On the 6th day after beginning 
this treatment, the pituitrin S and adrephine were discontinued and all the animals 
received daily for 3 successive days single instillations  of 5 per cent suspensions  of 
virus (1 cc. into each nostril).  The daily blood counts were continued for a period 
of about 2 weeks after the three doses of virus had been administered,  or until 
the animals succumbed. 
Experiment 26.--2 additional animals received daily for 7 days subcutaneous 
inoculations of increasing doses of adrephine.  The initial dose of adrephine was 
0.3 cc., and this was gradually increased so that the final dose was 1 cc.  Blood 
counts were taken on these animals daily for the 7 days, approximately 4 hours 
after subcutaneous inoculation of the adrephine. 
The total red blood ceils of the 6 animals in Experiment 25, with one exception, 
remained relatively uniform throughout the study, this single animal dying of a 
severe progressive anemia.  The white blood cells, however, showed frequent and 
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8,000 to a maximum of 30,000 per c.mm. without detectable cause.  These  varia- 
tions occurred in haphazard fashion throughout  all of the four phases of the 
experiment: the 4 days preliminary observation, the 5 days of treatment  with 
pituitrin S and adrephine, the 3 days during which the virus was administered, 
and the final 12 day period of observation.  This was true also of the differential 
counts particularly involving the adult segmented neutrophilic leucocytes, these 
frequently varying as much as 100 per cent without any appreciable associated 
changes in  the  total white counts.  Eosinophiles appeared with  considerable 
irregularity.  During the 4 day preliminary period of observation, they were 
found but 3 times in the total of 24 counts.  Two of the counts showed 1 per cent, 
the third 2 per cent.  During the period of treatment with pituitrin S and adreph- 
ine, the eosinophiles were found 15 times out of a total of 30 counts, the percentage 
varying from 1 per cent to 4 per cent.  During the 3 days when virus alone was 
administered, they were found 8 times in the 18 counts done.  In the 34 blood 
counts done during the last 12 days of the study, eosinophiles were observed 13 
times, varying from 1 per cent to 5 per cent of the total white count. 
There  appeared  to  be,  therefore,  a  tendency for eosinophiles to 
appear  more  frequently when  the  pitnitrin  S  and  adrephine  were 
administered, and to drop off slowly when these substances were dis- 
continued.  The figures, however, are small and no definite conclusion 
can be drawn. 
The presence of eosinophiles appears to have some relationship to 
the  occurrence  of intestinal parasites  in  this  experimental animal. 
Such infections are common in the monkey.  Ova of the parasites are 
frequently found in the stool, and at autopsy small cysts containing 
round worms are encountered along the root of the mesentery.  The 
animals used in Experiment 25 of the blood studies given above, were 
fresh stock recently imported from India.  Blood counts done for 2 
successive days on 6 animals which had been in the laboratory for a 
period of many months tended to show eosinophiles in their blood 
streams more  frequently; of  the  13  blood  counts done  on  these  6 
animals, from 1 per cent to 3 per cent eosinophiles were found 8 times, 
suggesting that old laboratory monkeys tend  to  show  eosinophiles 
more frequently, possibly as a result of their intestinal infestations. 
In the 2 animals which had received the adrephine by subcutaneous 
inoculation  (Experiment 26),  eosinophiles were found 7 times in the 
14  counts done, the percentage varying from 1 per cent to 3 per cent. 
There appeared to be no correlation between the appearance of eosino- 
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these  animals  remained  fairly  uniform,  whereas  the  white  cells 
tended to show similar, though less marked variations than the other 
animals studied. 
Actions of Pituitrin S  and Adrephine and Their Component Substances 
on the Virus in Vitro 
The following experiments were devised to determine the action of 
the components of pituitrin S and adrephine on the virus. 
The  commercial preparation  known  as  adrephine  is  an  acid  (hydrochloric) 
solution containing  adrenalin (1:10,000),  and 2 per cent ephedrine  sulfate with 
a pH of 4.04.2.  The pH of  the pituitrin S is about  3.4,  due to the  presence 
of acetic acid.  Both solutions  contain 0.5 per cent chloretone as a preservative. 
The following solutions were prepared: (a) hydrochloric acid, pH 4; (b) acetic acid, 
pH 3.4; (c) adrephine diluted with an equal amount of saline; (d) pituitrin S diluted 
with an equal amount of saline;  (e) 0.5 per cent solution of chloretone. 
Experiment g7.--To 1 cc. of each of these solutions,  0.1 cc. of normal monkey 
serum was added and the mixtures kept at room temperature for 1/6 hour.  Two 
infective doses of virus in 1 cc. of saline were then added to each test tube, thor- 
oughly shaken, placed in the incubator for 2 hours, and kept in the ice chest over- 
night.  The following morning 1.2 cc. from each test tube was inoculated intra- 
cerebrally into test animals.  2 controls were given virus and saline.  The test 
animal  inoculated  with  the  adrephine-virus  mixture  was  the  only  one  which 
survived, all the others, as well as both controls, developing the disease. 
Experiment 28.--A mixture was prepared of equal parts of adrephine and a 10 
per cent  virus  suspension  (Armstrong strain).  A  portion of this  mixture was 
permitted to stand at room temperature for 30 minutes, following which it was 
introduced into the nostrils of 2 normal monkeys (1 cc. into each nostril).  The 2 
control animals received 1 cc. of a 5 per cent suspension of virus into each nostril. 
The balance of the mixture of virus and adrephine was incubated for 2 hours at 
37°C. and kept overnight in the ice chest.  On the following morning 2 normal 
animals received intranasal instillations of this mixture (1 cc. into each nostril). 
2 control animals received instillations  of a 5 per cent suspension of virus which 
had been incubated for 2 hours and kept in the ice chest overnight.  This pro- 
cedure was repeated daffy for 3 successive days. 
The 2 animals which had received instillations of adrephine and virus 
kept  at  room temperature  for 30  minutes,  as well  as  the  2  controls 
which had received instillations  of 5  per cent virus suspensions,  suc- 
cumbed to the disease within the incubation period of the virus.  The 
2  animals  which  had  received  instillations  of  the  adrephine-virus 
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ice chest failed to  come down.  The  2  corresponding controls suc- 
cumbed to the experimental disease. 
It would therefore appear that under the experimental conditions, 
adrephine possesses some viricidal properties, although this is evident 
only after incubation at 37°C. and prolonged contact with the virus. 
Histologic Studies of the Mucous Membranes  of Animals Treated with 
Pituitrin S  and Adrephine 
Preliminary studies of the nasal mucous membranes of 12 animals 
treated with pituitrin S and adrephine show a mild active inflamma- 
tory reaction 12 to 96 hours after treatment.  There was hyperemia of 
the corium with local leucocytosis, margination, and exudation into 
the interstitial tissue.  This appeared to be a fairly constant feature 
in all of the sections studied.  Various types of leucocytes were found 
in varying numbers, and in several of the animals sacrificed 12 and 24 
hours after the last treatment, eosinophiles  were prominent both in 
the corium and migrating through the epithelial layer of the mucous 
membrane.  There was no desquamation or necrosis and edema was 
not conspicuous.  There was no fibrin lining the mucous layer.  This 
preliminary histologic investigation has  served to  indicate that  no 
severe inflammatory or degenerative effects are to be expected from 
instillations of these materials.  A more detailed study of the changes 
in the mucous membrane is being made. 
R~sum~ of the Findings 
The results of the preliminary experiments indicated that protection 
against intranasal infection was obtained in almost two-thirds of the 
animals which had received instillations of pituitrin S and adrephine 
twice a day for 5 days, when the intranasal test was begun 12 to 24 
hours after the last administration of pituitrin S and adrephine.  8 of 
the 11 animals which had received such treatment resisted two intra- 
nasal tests.  Only one of the 3 animals which had received virus 48 
hours after the last treatment of pituitrin S and adrephine survived. 
Of the 7 animals in these experiments which succumbed to the first 
intranasal test, 5 had been tested intranasally 48 to 96 hours after the 
treatment, and 2, 12 hours after treatment. 
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the  first  intranasal  test  gave  rise  to  an  active  immunity in  some 
instances, since of the 9 animals which had resisted the first intranasal 
test, 6 had developed neutralizing substance in their serums from 18 
to 21 days after the virus had been administered; all of these 9  sur- 
vivors resisted a second intranasal test, performed from 26 to 100 days 
after the first intranasal test, and 2 animals resisted the intracerebral 
test.  A third animal came down with a prolonged incubation period 
of 27 days, and a fourth animal came down with a mild attack of the 
disease from which it recovered. 
Eighteen animals received continued daily treatments with pitui- 
trin S and adrephine in combination with daily instillations of virus. 
6 of these 18 animals received one treatment a  day, and 12 animals 
received two daily treatments.  Of the 6 which had received a single 
treatment, 2 survived the intranasal test, one developed neutralizing 
substance in its serum, and both resisted an intracerebral test.  Of the 
12 animals which had received treatment twice a  day, 8 survived; 4 
of  these  developed neutralizing  substance  in  their  blood,  and  one 
serum partially neutralized the virus.  6 of the 8 resisted the intra- 
cerebral  test. 
Twenty-two additional animals received combined treatment  and 
virus instillations,  subsequent to 5 days preliminary treatment with 
pituitrin  S  and  adrephine  before  administration  of  the  virus  was 
started.  10 of these 22 animals received one treatment with pituitrin 
S and adrephine a day, and 12 animals received two such treatments a 
day.  Of the  10  animals which had received a  single treatment in 
combination with virus,  2  survived the procedures.  Both  of these 
animals  resisted  intranasal  infection;  both  developed  neutralizing 
substance in their serums, and resisted the intracerebral test.  Of the 
12 animals which had received two treatments a day in combination 
with virus,  10 survived; 9 of the animals resisted the intranasal test, 
8 developed neutralizing substance in their serums, and 9 resisted the 
intracerebral test. 
In the two small experiments in which adrephine alone was used, the 
results were essentially the same as when pituitrin S and adrephine 
were employed.  The 2 animals  a which had received 5 days of treat- 
6 A third animal used in this experiment died from an intercurrent infection 
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ment with adrephine twice a day and intranasal test begun 12 hours 
after the last treatment, survived; both animals developed  neutralizing 
substance in their blood serum, resisted a second intranasal test, and 
both  resisted  an  intracerebral  test.  Of  the  4  animals  which had 
received daily administration of adrephine alone in combination with 
virus,  2  survived the  prolonged exposure  to  adrephine  and  virus. 
Both animals survived intranasal tests, developed neutralizing sub- 
stance in  their  serums and  survived the intracerebral  test.  There 
was little or no indication that pituitrin S when used alone afforded 
protection, since all 3  animals thus treated succumbed, though 2 of 
them lived for 21 days after the beginning of the experiment, and the 
third for 18 days. 
Pituitrin S and adrephine adm~uistered subcutaneously afforded no 
protection against intranasal infection, nor did these substances appear 
to exert a delayed reaction when administered by the intranasal route 
since all of the animals tested intranasally, 2, 4, and 6 weeks after the 
7 days treatment, succumbed. 
There was some suggestion that the intranasal and subcutaneous 
administration of pituitrin S and adrephine resulted in a slight eosino- 
philic response in the blood stream, but this appeared to be transient 
and was not marked.  A  somewhat more pronounced local eosino- 
philic response, however, was noted in the mucous membranes of the 
animals which had received intranasal instillations of pituitrin S and 
adrephine.  This was noted  in  animals sacrificed  12  and  24  hours 
after  treatment.  The  eosinophiles were  part  of  the  mild general 
inflammatory reaction of the mucous membranes in all of the treated 
animals. 
There was some indication that adrephine possessed some viricidal 
action, but this was evident only after incubation for 2 hours at 37°C., 
and prolonged contact with the virus. 
In the seven comparable experiments in which solutions of alum 
sulfate-picric acid and zinc sulfate were employed in place of pituitrin 
S  and adrephine, there was no indication of any alteration in  the 
underlying susceptibility of the animals, as indicated by their failure 
to develop neutralizing substance in their blood and their inability 
to resist the intracerebral test.  Most of the animals treated with zinc 
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Animals treated with alum sulfate-picric acid showed a less constant 
protection against intranasal infection, than the zinc sulfate-treated 
animals.  The survivors of both groups of animals succumbed to the 
intracerebral  test. 
SITM~tARY 
The experiments reported above indicate that the intranasal instilla- 
tions of pituitrin S and adrephine, alter susceptibility in the rhesus 
monkey.  One-half to two-thirds of the treated animals resisted intra- 
nasal infection, and, moreover, most of the resistant animals which 
had received combined treatment and virus developed active immu- 
nity, as indicated by the presence of neutralizing substance in their 
serums and by their ability to resist intracerebral infection.  We have, 
it appears, not alone modified in some fashion the usual reaction of 
this  animal  to  intranasal  infection,  but  we  have  also  successfully 
vaccinated these animals by the nasal route, so that the response in 
animals more nearly approaches what we believe to be the response in 
human beings. 
We have no knowledge of the mechanism by means of which pitui- 
trin S and adrephine produce this apparent alteration in susceptibility, 
but since the outcome of continued exposure to virus in most of the 
animals treated with these substances results in immunity, we believe 
that this offers a  more hopeful approach toward the control of the 
disease. 